EP 1594443 A2 20051116 - IMMUNOGENIC CD19 LIGAND-ANTIGENIC MOLECULE COMPLEXES AND FUSION PROTEINS
Title (en)
IMMUNOGENIC CD19 LIGAND-ANTIGENIC MOLECULE COMPLEXES AND FUSION PROTEINS
Title (de)
IMMUNOGENE CD19 LIGANDEN-ANTIGEN-MOLEKÜL-KOMPLEXE UND FUSIONSPROTEINE
Title (fr)
COMPLEXES MOLECULAIRES IMMUNOGENIQUES D'UN LIGAND CD91-ANTIGENE ET PROTEINES HYBRIDES
Publication
Application
Priority
- US 2004003642 W 20040204
- US 44476903 P 20030204
Abstract (en)
[origin: WO2004080387A2] The present invention relates to complexes and fusion proteins comprising a CD91 ligand and an antigenic molecule, for use in the treatment or prevention of a disease. The invention specifically provides complexes comprising a CD91 ligand noncovalently boundto, or alternatively crosslinked to, an antigenic molecule. The invention also specifically provides fusion proteins comprising a CD91 ligand fused via a peptide bond to an antigenic molecule.
IPC 1-7
IPC 8 full level
A61K 6/00 (2006.01); A61K 39/00 (2006.01); C07K 19/00 (2006.01)
IPC 8 main group level
A61K (2006.01)
CPC (source: EP)
A61K 39/00 (2013.01); A61K 2039/55511 (2013.01); A61K 2039/60 (2013.01)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2004080387 A2 20040923; WO 2004080387 A3 20090326; AU 2004220627 A1 20040923; CA 2515286 A1 20040923; EP 1594443 A2 20051116
DOCDB simple family (application)
US 2004003642 W 20040204; AU 2004220627 A 20040204; CA 2515286 A 20040204; EP 04737304 A 20040204